MedTrace Logo

Added Value of N Acetyle Cysteine to Clomiphene Citrate in PCO

NCT04170439 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2021-04-28

No results posted yet for this study

Summary

PCO is one of the factors associated with delayed conception

Conditions

  • PCO

Interventions

DRUG

Clomiphene plus metformin plus N acetyle cysteine in arm number 1

oral adminstration of clomiphene citrate plus metformin plus N acetyl cysteine or chromium

DRUG

Clomiphene citrate plus metformin with chromium

oral adminstration of clomiphene citrate plus metformin and chromium

DRUG

clomiphene citrate plus metformin

oral adminstration of clomiphene citrate plus metformin

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER

  • Aljazeera Hospital

    lead OTHER

Principal Investigators

  • Mahmoud Alalfy, PhD · Algezeera

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-20
Primary Completion
2020-05-02
Completion
2020-05-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04170439 on ClinicalTrials.gov